infliximab Synonyms
No Synonyms and anytonyms found
infliximab Meaning
infliximab (n)
a monoclonal antibody (trade name Remicade) used to treat Crohn's disease and rheumatoid arthritis; administered by infusion; use and dosage must be determined by a physician
an anti-TNF compound (trade name Remicade) consisting of an antibody directed against TNF; it is given intravenously at one-month to three-month intervals; used in treatment of regional enteritis and rheumatoid arthritis
infliximab Sentence Examples
- Infliximab is a monoclonal antibody medication primarily used to treat inflammatory bowel disease.
- Infliximab is administered intravenously and targets the tumor necrosis factor-alpha (TNF-alpha) protein.
- Patients with Crohn's disease and ulcerative colitis often receive infliximab to reduce inflammation and improve symptoms.
- Infliximab therapy has been shown to induce clinical remission in a significant proportion of patients with inflammatory bowel disease.
- Infliximab can cause side effects such as infusion reactions, increased risk of infections, and allergic reactions.
- Monitoring for potential side effects is crucial during infliximab treatment.
- Infliximab is contraindicated in patients with active infections or a history of severe allergic reactions.
- The frequency of infliximab infusions varies depending on the individual patient's condition and response to the medication.
- Infliximab has been approved for use in several countries worldwide for the treatment of inflammatory bowel disease.
- Research is ongoing to evaluate the effectiveness and safety of infliximab in treating other immune-mediated conditions.
FAQs About the word infliximab
a monoclonal antibody (trade name Remicade) used to treat Crohn's disease and rheumatoid arthritis; administered by infusion; use and dosage must be determined
No synonyms found.
No antonyms found.
Infliximab is a monoclonal antibody medication primarily used to treat inflammatory bowel disease.
Infliximab is administered intravenously and targets the tumor necrosis factor-alpha (TNF-alpha) protein.
Patients with Crohn's disease and ulcerative colitis often receive infliximab to reduce inflammation and improve symptoms.
Infliximab therapy has been shown to induce clinical remission in a significant proportion of patients with inflammatory bowel disease.
